Jane Street’s Zealand Pharma A/S American Depositary Shares ZEAL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-23,976
| Closed | -$312K | – | 10851 |
|
|
2022
Q2 | $312K | Buy |
23,976
+262
| +1% | +$3.36K | ﹤0.01% | 7553 |
|
|
2022
Q1 | $369K | Sell |
23,714
-727
| -3% | -$12.3K | ﹤0.01% | 8047 |
|
|
2021
Q4 | $522K | Buy |
24,441
+14,409
| +144% | +$367K | ﹤0.01% | 7182 |
|
|
2021
Q3 | $295K | Sell |
10,032
-22,178
| -69% | -$668K | ﹤0.01% | 8232 |
|
|
2021
Q2 | $946K | Sell |
32,210
-8,380
| -21% | -$262K | ﹤0.01% | 5960 |
|
|
2021
Q1 | $1.3M | Buy |
40,590
+4,883
| +14% | +$164K | ﹤0.01% | 4944 |
|
|
2020
Q4 | $1.28M | Buy |
35,707
+9,352
| +35% | +$352K | ﹤0.01% | 4261 |
|
|
2020
Q3 | $1.01M | Sell |
26,355
-9,976
| -27% | -$361K | ﹤0.01% | 4081 |
|
|
2020
Q2 | $1.27M | Buy |
36,331
+19,675
| +118% | +$699K | ﹤0.01% | 3723 |
|
|
2020
Q1 | $575K | Buy |
16,656
+3,022
| +22% | +$105K | ﹤0.01% | 3474 |
|
|
2019
Q4 | $482K | Buy |
13,634
+1,692
| +14% | +$50.6K | ﹤0.01% | 3728 |
|
|
2019
Q3 | $304K | Buy |
+11,942
| New | +$270K | ﹤0.01% | 4173 |
|
|
2019
Q1 | – | Sell |
-25,285
| Closed | -$320K | – | 5867 |
|
|
2018
Q4 | $320K | Buy |
+25,285
| New | +$332K | ﹤0.01% | 3994 |
|
|
2018
Q2 | – | Sell |
-10,798
| Closed | -$166K | – | 5816 |
|
|
2018
Q1 | $166K | Sell |
10,798
-7,760
| -42% | -$121K | ﹤0.01% | 4512 |
|
|
2017
Q4 | $254K | Sell |
18,558
-1,441
| -7% | -$22.6K | ﹤0.01% | 3939 |
|
|
2017
Q3 | $386K | Buy |
+19,999
| New | +$377K | ﹤0.01% | 3407 |
|
Other funds holding ZEAL
Jane Street's ZEAL Position: Q3 2022 in Review
Jane Street sold out of Zealand Pharma A/S American Depositary Shares (ZEAL) in Q3 2022, closing a stake of 23,976 shares — an estimated $312K sold.
Jane Street first reported a position in ZEAL in Q3 2017 and held it in 16 quarters. The position peaked at $1.3M in Q1 2021. 1 fund tracked by Wall St. Rank holds ZEAL as of Q3 2022.
- Jane Street reported no remaining Zealand Pharma A/S American Depositary Shares position as of Q3 2022 after selling out during the quarter.
- Jane Street sold 23,976 Zealand Pharma A/S American Depositary Shares shares in Q3 2022, an estimated $312K.
- Jane Street first reported a position in Zealand Pharma A/S American Depositary Shares in Q3 2017 and held it in 16 quarters.
- Jane Street's Zealand Pharma A/S American Depositary Shares position peaked at $1.3M in Q1 2021.
- 1 fund tracked by Wall St. Rank held Zealand Pharma A/S American Depositary Shares as of Q3 2022.
Based on Jane Street's 13F filing for Q3 2022, filed 15 Nov 2022.